Taubman Institute Call for Nominations

 

The A. Alfred Taubman Medical Research Institute is seeking qualified candidates to fill a vacancy in its Taubman Scholars Program.

The Taubman Scholars Program is the core initiative of the Taubman Institute, providing University of Michigan senior physician-scientists with financial support designed to foster translational research. The goal of the program is to accelerate the pace with which laboratory discoveries are transformed into new patient treatments.

Taubman Scholars receive grants of $150,000 per year for three years. Although the Taubman Institute provides grants for research on a wide spectrum of diseases, it has core areas of inquiry: cancer, cardiovascular disease, diabetes and other metabolic diseases, and neurological disorders. It also seeks to fund scientists working in the emerging technologies of advanced imaging and surgical devices, who will collaborate with other Scholars to allow for the rapid translation of new ideas into actual therapies.

Eligibility is restricted to:

• University of Michigan senior faculty, associate or full professors

• Holders of medical degrees (an M.D. or M.D./Ph.D.)

• Clinician-scientists, individuals who are conducting basic research while maintaining an active clinical practice.

• Scientists whose research focuses on translational research

The deadline for applications is April 1, 2013.  All applications should be submitted electronically using this form on the Taumbman Institute website.

Once an application is received, it will be reviewed by the Director of the Taubman Institute to ensure applicant eligibility before being submitted to the Taubman Institute Scientific Advisory Board for evaluation. The Scientific Advisory Board, comprised of nationally prominent clinician-scientists, will make funding recommendations to the Director and to the members of the Governing Council of the Taubman Institute, who possess the ultimate grant-making authority.

The criteria for making such decisions include:

• Quality and scope of the proposed research from applicants who meet all eligibility requirements

• Translational nature of the proposed research

• The “high risk, high reward” nature of the proposed research, which would render it unlikely to receive funding from traditional sources

• Its alignment with the current scientific objectives of the Institute, as determined by the Director and Governing Council

Barring any unforeseen delays, the effective date of this grant will be July 1, 2013.

A new Taubman Scholar is responsible for opening an account in his or her Medical School department to which the grant funding will be transferred. It is the responsibility of that department to monitor all expenses for which this grant is used to make certain that they are in accordance with all University of Michigan policies and regulations.

Questions? Please contact Taubman Institute Managing Director Martin Fischhoff at (734) 615-7130 or This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists